STLN financials
Starling Oncology (STLN) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
STLN income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $502.73M | – | -$36.08M | -$50.30M | -0.54 |
| 2024 | $393.41M | – | -$60.12M | -$53.01M | -0.71 |
| 2023 | $324.24M | – | -$77.02M | -$67.88M | -0.92 |
| 2022 | $252.48M | – | -$81.95M | $68.00K | -0.21 |
| 2021 | $203.00M | – | -$45.86M | -$10.63M | -0.16 |
| 2020 | $187.51M | – | -$8.20M | -$14.32M | -0.24 |
- STLN revenue was $502.73M in fiscal 2025, net income -$50.30M.
Updated 2026-11-11 00:49 UTC